Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.
about
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteersEscherichia coli heat-labile detoxified enterotoxin modulates dendritic cell function and attenuates allergic airway inflammationSide-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primatesIntranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in miceIntranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5.Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins.Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in miceBinding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I)The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin.Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response.The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skinEnhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticlesOptimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vectorActive and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.Helicobacter pylori vaccines: lessons from small animal models.Living dangerously: how Helicobacter pylori survives in the human stomach.Defined synthetic vaccines.Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/IRole of heat-stable enterotoxins in the induction of early immune responses in piglets after infection with enterotoxigenic Escherichia coli.Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functionsGenetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain.New strategies for the prevention and treatment of Helicobacter pylori infection.Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responsesOral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malariaThe M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.Antibacterial and antidiarrheal activities of plant products against enterotoxinogenic Escherichia coli.Unexpected modulation of recall B and T cell responses after immunization with rotavirus-like particles in the presence of LT-R192G.Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines.Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine.Can nonliving nasal vaccines be made to work?A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phasEffects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent.Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea PigsInduction of cell signaling events by the cholera toxin B subunit in antigen-presenting cellsPollen grains for oral vaccination
P2860
Q24545856-996BA471-0FF1-4BFA-9C18-216BD3C10A05Q27318601-5BC9C6F5-B9CB-43C4-9F81-677EC60EE37CQ27325586-296168F6-7CE5-479D-B80A-4524C8C2E946Q28744391-BC03662B-8AF5-4CC6-A8C7-46FC6AD97A4AQ30356284-6710972B-4327-44DD-8328-9FDB5A4129C0Q33597022-565C7A7F-8844-4ED9-876C-38DAD48BF1E2Q33716162-4B2C0F8D-AF11-4745-BBFB-18D4F2C1AD4BQ33843895-E8479E02-C12F-484F-9A0E-3E6620D70ED0Q33909162-75B31D55-2D27-4E97-9D4D-C87FE8C8ECBFQ33955531-9EBB8331-C6F3-4DDC-8261-44FF14476C48Q34007453-9E056ED2-A91E-4423-A335-7D7FC2DCD060Q34009465-A6A5FB81-C420-44CB-A3A1-E28B16CC0F26Q34123358-0209B339-2BF9-403B-B88C-DE4C1F58526BQ34130228-23FA2AC9-6B46-4BFF-BB18-534FA849C5CCQ34166320-D099F9AF-203E-4AC7-88C1-85DDCC1A44D5Q34194488-99EA70C0-638A-4928-97B3-F9A004280FC2Q34222745-8E9E1C0F-604D-4554-919F-575E83C6E5BCQ34271593-F138DDFD-B19D-4874-A654-31565EA716C7Q34280941-60DDAD36-8108-4287-9260-65E63FD85F7CQ34334284-99443EE9-0012-4B78-AA53-9AC3F9AA020CQ34345547-7063010B-E746-47DF-88BA-954AA1E30388Q34353344-CA2DC0F1-2643-4A05-8293-24F051682EFCQ34715639-7F76AC8F-5A3B-4AEE-8CDB-49D4ACCE3828Q34716080-0DEDEE61-3910-4AD5-83D9-F23F2CDA25ACQ34768573-6E024F9A-8FEF-4EB5-A11F-28B2D2C70B65Q34852816-C8B8A156-2301-4261-A4FA-F4212DBE8162Q34933206-3CFA9B35-D583-4C01-B7C5-2A9C6A32C142Q34983762-0B5720EA-F835-40D5-81E4-CB788E836432Q34998726-F5284DB3-0E3B-4171-AFE0-8D5F5C4CA551Q35037922-A319C8AD-2DEA-416F-846E-AC3EE2842666Q35155937-9BC0E478-33E8-4236-8D8A-CC25349BCAB2Q35192203-0B44E220-3C23-4CC6-9363-4A51820F9544Q35192206-DD38D3FF-B134-4F53-8A22-5585010DFFA4Q35193442-114AD2D6-3039-4B76-AD56-332D6BB500CDQ35598235-F6B98D41-CB24-4D1E-8B8B-22E6D974E1CFQ35619878-A69BD61B-EBEE-4498-B74D-A8729F7523F4Q35689341-1E23885A-B633-4291-86B9-B198CFAE188CQ35692346-CA509F7F-74E5-4297-B2A9-95F37B99F379Q35913540-E569F0C6-6E23-47B0-993E-8D043C666C0FQ36100539-1A06BD6B-7EAC-47A9-A71A-31E465869E02
P2860
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Structure and mucosal adjuvant ...... coli heat-labile enterotoxins.
@ast
Structure and mucosal adjuvant ...... coli heat-labile enterotoxins.
@en
type
label
Structure and mucosal adjuvant ...... coli heat-labile enterotoxins.
@ast
Structure and mucosal adjuvant ...... coli heat-labile enterotoxins.
@en
prefLabel
Structure and mucosal adjuvant ...... coli heat-labile enterotoxins.
@ast
Structure and mucosal adjuvant ...... coli heat-labile enterotoxins.
@en
P2093
P1433
P1476
Structure and mucosal adjuvant ...... coli heat-labile enterotoxins.
@en
P2093
P304
P356
10.1016/S0167-5699(99)01523-6
P577
1999-11-01T00:00:00Z